Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbaud

Showing results (441-450 of 532) with videos related to

Pageof 54
Sort By:
Journal of the American Academy of Dermatology|July 15, 2019
Treatment of calcinosis cutis in systemic sclerosis and dermatomyositis: A review of the literatureHélène Traineau, Rohit Aggarwal, Jean-Benoît Monfort, et al.
International Wound Journal|September 14, 2013
Role of nicotinic acid and nicotinamide in nicorandil-induced ulcerations: from hypothesis to demonstrationPhilippe Trechot, Jean-Yves Jouzeau, Clotilde Brouillard, et al.
Annales De Dermatologie Et De Venereologie|May 15, 2012
[Skin toxicity related to Percutalgine(®): analysis of the French pharmacovigilance database]C Remy, A Barbaud, B Lebrun-Vignes, et al.
Allergy|July 21, 2018
EAACI position paper on how to classify cutaneous manifestations of drug hypersensitivityKnut Brockow, Michael R Ardern-Jones, Maja Mockenhaupt, et al.
Journal of Wound Care|June 25, 2005
Study to determine the efficacy of topical morphine on painful chronic skin ulcersC Vernassiere, C Cornet, P Trechot, et al.
Cancers|September 5, 2019
Exploring Tumor Heterogeneity Using PET Imaging: The Big PictureClément Bailly, Caroline Bodet-Milin, Mickaël Bourgeois, et al.
The Journal of Allergy and Clinical Immunology|July 26, 2011
Delayed hypersensitivity reactions caused by iodixanol: an assessment of cross-reactivity in 22 patientsFrédéric Hasdenteufel, Julie Waton, Vanina Cordebar, et al.
Journal of the American Academy of Dermatology|March 3, 2018
Risk of thromboembolic events in patients treated with thalidomide for cutaneous lupus erythematosus: A multicenter retrospective studyElise Cesbron, Didier Bessis, Marie Jachiet, et al.
Annales De Dermatologie Et De Venereologie|April 17, 2018
[Treatment of severe cutaneous adverse drug reactions]S Ingen-Housz-Oro, T-A Duong, N de Prost, et al.
Allergy|June 9, 2020
Diagnosis and management of the drug hypersensitivity reactions in Coronavirus disease 19: An EAACI Position PaperAslı Gelincik, Knut Brockow, Gülfem E Çelik, et al.
Pageof 54

Showing results (441-450 of 532) with videos related to

Sort By:
Pageof 54
Journal of the American Academy of Dermatology|July 15, 2019
Treatment of calcinosis cutis in systemic sclerosis and dermatomyositis: A review of the literatureHélène Traineau, Rohit Aggarwal, Jean-Benoît Monfort, et al.
International Wound Journal|September 14, 2013
Role of nicotinic acid and nicotinamide in nicorandil-induced ulcerations: from hypothesis to demonstrationPhilippe Trechot, Jean-Yves Jouzeau, Clotilde Brouillard, et al.
Annales De Dermatologie Et De Venereologie|May 15, 2012
[Skin toxicity related to Percutalgine(®): analysis of the French pharmacovigilance database]C Remy, A Barbaud, B Lebrun-Vignes, et al.
Allergy|July 21, 2018
EAACI position paper on how to classify cutaneous manifestations of drug hypersensitivityKnut Brockow, Michael R Ardern-Jones, Maja Mockenhaupt, et al.
Journal of Wound Care|June 25, 2005
Study to determine the efficacy of topical morphine on painful chronic skin ulcersC Vernassiere, C Cornet, P Trechot, et al.
Cancers|September 5, 2019
Exploring Tumor Heterogeneity Using PET Imaging: The Big PictureClément Bailly, Caroline Bodet-Milin, Mickaël Bourgeois, et al.
The Journal of Allergy and Clinical Immunology|July 26, 2011
Delayed hypersensitivity reactions caused by iodixanol: an assessment of cross-reactivity in 22 patientsFrédéric Hasdenteufel, Julie Waton, Vanina Cordebar, et al.
Journal of the American Academy of Dermatology|March 3, 2018
Risk of thromboembolic events in patients treated with thalidomide for cutaneous lupus erythematosus: A multicenter retrospective studyElise Cesbron, Didier Bessis, Marie Jachiet, et al.
Annales De Dermatologie Et De Venereologie|April 17, 2018
[Treatment of severe cutaneous adverse drug reactions]S Ingen-Housz-Oro, T-A Duong, N de Prost, et al.
Allergy|June 9, 2020
Diagnosis and management of the drug hypersensitivity reactions in Coronavirus disease 19: An EAACI Position PaperAslı Gelincik, Knut Brockow, Gülfem E Çelik, et al.
Pageof 54